OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023

OpSens Anticipates the Results of the SAFE-TAVI Clinical Study on October 25

OpSens to Host a Satellite Program on October 25, 6:30-7:30 am PT

QUEBEC, Oct. 17, 2023 /CNW/ - OpSens Inc. ("OpSens" or the "Company") (TSX:OPS.TO) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it will participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT), October 23-26, 2023. The event will be held at the Moscone Center, San Francisco, CA. The TCT is an annual scientific symposium of the Cardiovascular Research Foundation (CRF) and the premier educational meeting specializing in interventional cardiovascular medicine, attracting more than 10,000 attendees from over 90 countries around the world.